We first found that CUEDC1 was significantly downregulated in adrenocortical carcinoma, bladder urothelial carcinoma, colon adenocarcinoma, kidney renal clear cell carcinoma, prostate adenocarcinoma and thyroid carcinoma tissues (Supplementary Figure 1A). Here, CUEDC1 is linked to bladder transitional cell carcinoma.